CAS: 6926-14-3 - 8-O-Acetylharpagide
Formule :C17H26O11
InChI :InChI=1S/C17H26O11/c1-7(19)28-16(2)5-9(20)17(24)3-4-25-15(13(16)17)27-14-12(23)11(22)10(21)8(6-18)26-14/h3-4,8-15,18,20-24H,5-6H2,1-2H3/t8-,9-,10-,11+,12-,13-,14+,15+,16+,17-/m1/s1
Code InChI :InChIKey=CAFTUQNGDROXEZ-XBDCZORHSA-N
SMILES :O=C(OC1(C)CC(O)C2(O)C=COC(OC3OC(CO)C(O)C(O)C3O)C21)C
- Synonymes :
- (1S,4aS,5R,7S,7aS)-7-(Acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methylcyclopenta[c]pyran-1-yl β-<span class="text-smallcaps">D</span>-glucopyranoside
- (4aS,7S,7aS)-7-methyl-1-{[(2S,3R,4R,6R)-3,4,5,5,6-pentahydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate (non-preferred name)
- 8-Acetylharpagide
- 8-O-Acetylharpagide
- Glucopyranoside, 1β,4a,5,6,7,7aα-hexahydro-4aα,5α,7α-trihydroxy-7-methylcyclopenta[c]pyran-1-yl, 7-acetate, β-<span class="text-smallcaps">D</span>-
- Harpagide acetate
- Harpagide, 8-acetate
- O-Acetylharpagide, 8-
- β-<span class="text-smallcaps">D</span>-Glucopyranoside, (1S,4aS,5R,7S,7aS)-7-(acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methylcyclopenta[c]pyran-1-yl
- β-<span class="text-smallcaps">D</span>-Glucopyranoside, 7-(acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methylcyclopenta[c]pyran-1-yl, [1S-(1α,4aα,5α,7α,7aα)]-
- Voir d'autres synonymes
- β-D-Glucopyranoside, 7-(acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methylcyclopenta[c]pyran-1-yl, [1S-(1α,4aα,5α,7α,7aα)]-
- Glucopyranoside, 1β,4a,5,6,7,7aα-hexahydro-4aα,5α,7α-trihydroxy-7-methylcyclopenta[c]pyran-1-yl, 7-acetate, β-D-
- β-D-Glucopyranoside, (1S,4aS,5R,7S,7aS)-7-(acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methylcyclopenta[c]pyran-1-yl
- (1S,4aS,5R,7S,7aS)-7-(Acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methylcyclopenta[c]pyran-1-yl β-D-glucopyranoside
| Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
|---|---|---|---|---|
 | 8-O-acetylharpagide REF : IN-DA00FCUXCAS : 6926-14-3 | 97% | 53,00 €~553,00 € | mer 08 Jan 25 |
 | 8-Acetylharpagide REF : 7W-GL9222CAS : 6926-14-3 | - - - | À demander | jeu 09 Jan 25 |
 | 8-Acetylharpagide REF : BP-BP0105CAS : 6926-14-3 | 95%~99% | 59,00 €~679,00 € | lun 13 Jan 25 |
 | 8-O-Acetylharpagide REF : TM-T6S2025CAS : 6926-14-3 | 99.49% | 54,00 €~87,00 € | mer 15 Jan 25 |
 | 8-acetylharpagide REF : 5G-82700CAS : 6926-14-3 | ≥ 95.0 % (HPLC) | 258,00 €~17.473,00 € | ven 17 Jan 25 |
 | Acetylharpagide REF : 3D-FA73988CAS : 6926-14-3 | Min. 95% | À demander | mer 19 Fév 25 |
8-O-acetylharpagide
CAS :6926-14-3
Formule :
C17H26O11
Degré de pureté :
97%
Couleur et forme :
Solid
Masse moléculaire :
406.3817
Ref: IN-DA00FCUX
| 1mg | 53,00 € | ||
| 5mg | 107,00 € | ||
| 25mg | 146,00 € | ||
| 50mg | 246,00 € | ||
| 100mg | 553,00 € |
Livraison estimée en/au États-Unis, le mercredi 8 janvier 2025
Ref: BP-BP0105
| 20mg | 59,00 € | ||
| 100mg | 179,00 € | ||
| 1000mg | 679,00 € |
Livraison estimée en/au États-Unis, le lundi 13 janvier 2025
8-O-Acetylharpagide
CAS :6926-14-3
8-O-Acetylharpagide is a cyclic enol ether terpene isolated from Ajuga reptans with antitumour, antiviral, antibacterial …
Formule :
C17H26O11
Degré de pureté :
99.49%
Couleur et forme :
Solid
Masse moléculaire :
406.38
Ref: TM-T6S2025
| 20mg | 87,00 € | ||
| 1mL*10mM (DMSO) | 55,00 € |
Livraison estimée en/au États-Unis, le mercredi 15 janvier 2025
8-acetylharpagide
CAS :6926-14-3
Natural glycoside
Formule :
C17H26O11
Degré de pureté :
≥ 95.0 % (HPLC)
Masse moléculaire :
406.38
Ref: 5G-82700
| 10mg | 258,00 € | ||
| 50mg | 1.049,00 € | ||
| 250mg | 4.951,00 € | ||
| 500mg | 9.319,00 € | ||
| 1000mg | 17.473,00 € |
Livraison estimée en/au États-Unis, le vendredi 17 janvier 2025
Acetylharpagide
CAS :6926-14-3
Acetylharpagide is a prodrug that is hydrolyzed to harpagoside, its active form. Acetylharpagide binds to …
Degré de pureté :
Min. 95%
Ref: 3D-FA73988
| 5mg | À demander | ||
| 10mg | À demander | ||
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Livraison estimée en/au États-Unis, le mercredi 19 février 2025
